
Global Colorectal Cancer Diagnostics Market - Industry Trends and Forecast to 2030
Description
Global Colorectal Cancer Diagnostics Market - Industry Trends and Forecast to 2030
Global Colorectal Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Stool Examination, Blood Test, Imaging Test, Tumor Markers, Biopsy, and Others), Stages (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors, and Others), Age Group (Geriatric, Adults, and Pediatric), End User (Hospital, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, Academic Institutes, and Others),, Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Belgium, Switzerland, Rest of Europe, China, India, Japan, South Korea, Thailand, Singapore, Indonesia, Malaysia, Philippines, Australia, Vietnam and Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa), Industry Trends and Forecast to 2030
Market Definition:
Colorectal cancer starts in the colon or the rectum. Depending on where they start, these cancers can also be called colon cancer or rectal cancer. Colon cancer and rectal cancer are often grouped because they have many features in common. Colorectal cancer is a disease in which cells in the colon or rectum grow out of control. Sometimes it is called colon cancer, short. The colon is the large intestine or large bowel. The rectum is the passageway that connects the colon to the anus.
Sometimes abnormal growths, called polyps, form in the colon or rectum. Over time, some polyps may turn into cancer. Screening tests can find polyps so they can be removed before becoming cancer. Screening also helps find colorectal cancer early, when treatment works best.
Market Segmentation:
Global colorectal cancer diagnostics market is categorized into six notable segments such as product type, test type, stages, cancer type, age group, and end user.
• On the basis of product type, the global colorectal cancer diagnostics market is segmented into instruments and consumables & accessories
• On the basis of test type, the global colorectal cancer diagnostics market is segmented into stool examination, imaging tests, biopsy, blood tests, tumor markers, and others
• On the basis of stages, the global colorectal cancer diagnostics market is segmented into stage 0, stage I, stage II, stage III, and stage IV
• On the basis of cancer type, the global colorectal cancer diagnostics market is segmented into adenocarcinoma, colorectal lymphoma, gastrointestinal stromal tumors, carcinoid tumors, and others
• On the basis of age group, the global colorectal cancer diagnostics market is segmented into pediatric, adult, and geriatric
• On the basis of end user, the global colorectal cancer diagnostics market is segmented into hospitals, diagnostic centers, cancer research centers, ambulatory surgical centers, academic institutes, and others
Market Players
Some of the major players operating in the global throat cancer diagnostics market are:
• F. Hoffmann-La Roche Ltd
• Koninklijke Philips N.V.
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• Quest Diagnostics Incorporated
• Canon Medical Systems Corporation
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• FUJIFILM Corporation
• Agilent Technologies, Inc.
• BD
• General Electric Company
• Siemens Healthcare GmbH
• Abbott
• Neusoft Corporation
• BioFire Diagnostics
• Myriad Genetics Inc.
• QIAGEN
• Hologic, Inc.
• Time Medical Holding.
• FONAR Corp.
• GE HealthCare.
• PlexBio.
• SternMed GmbH.
• MinFound Medical Systems Co., Ltd
• Medonica Co. LTD
• Beijing O&D Biotech Co., Ltd.
Global Colorectal Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Stool Examination, Blood Test, Imaging Test, Tumor Markers, Biopsy, and Others), Stages (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors, and Others), Age Group (Geriatric, Adults, and Pediatric), End User (Hospital, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, Academic Institutes, and Others),, Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Belgium, Switzerland, Rest of Europe, China, India, Japan, South Korea, Thailand, Singapore, Indonesia, Malaysia, Philippines, Australia, Vietnam and Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa), Industry Trends and Forecast to 2030
Market Definition:
Colorectal cancer starts in the colon or the rectum. Depending on where they start, these cancers can also be called colon cancer or rectal cancer. Colon cancer and rectal cancer are often grouped because they have many features in common. Colorectal cancer is a disease in which cells in the colon or rectum grow out of control. Sometimes it is called colon cancer, short. The colon is the large intestine or large bowel. The rectum is the passageway that connects the colon to the anus.
Sometimes abnormal growths, called polyps, form in the colon or rectum. Over time, some polyps may turn into cancer. Screening tests can find polyps so they can be removed before becoming cancer. Screening also helps find colorectal cancer early, when treatment works best.
Market Segmentation:
Global colorectal cancer diagnostics market is categorized into six notable segments such as product type, test type, stages, cancer type, age group, and end user.
• On the basis of product type, the global colorectal cancer diagnostics market is segmented into instruments and consumables & accessories
• On the basis of test type, the global colorectal cancer diagnostics market is segmented into stool examination, imaging tests, biopsy, blood tests, tumor markers, and others
• On the basis of stages, the global colorectal cancer diagnostics market is segmented into stage 0, stage I, stage II, stage III, and stage IV
• On the basis of cancer type, the global colorectal cancer diagnostics market is segmented into adenocarcinoma, colorectal lymphoma, gastrointestinal stromal tumors, carcinoid tumors, and others
• On the basis of age group, the global colorectal cancer diagnostics market is segmented into pediatric, adult, and geriatric
• On the basis of end user, the global colorectal cancer diagnostics market is segmented into hospitals, diagnostic centers, cancer research centers, ambulatory surgical centers, academic institutes, and others
Market Players
Some of the major players operating in the global throat cancer diagnostics market are:
• F. Hoffmann-La Roche Ltd
• Koninklijke Philips N.V.
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• Quest Diagnostics Incorporated
• Canon Medical Systems Corporation
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• FUJIFILM Corporation
• Agilent Technologies, Inc.
• BD
• General Electric Company
• Siemens Healthcare GmbH
• Abbott
• Neusoft Corporation
• BioFire Diagnostics
• Myriad Genetics Inc.
• QIAGEN
• Hologic, Inc.
• Time Medical Holding.
• FONAR Corp.
• GE HealthCare.
• PlexBio.
• SternMed GmbH.
• MinFound Medical Systems Co., Ltd
• Medonica Co. LTD
• Beijing O&D Biotech Co., Ltd.
Table of Contents
402 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The Global Colorectal Cancer Diagnostics Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product Type Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market End User Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Porter’s Five Forces
- 4.2 Pestel Analysis
- 5 Industry Insights:
- 6 Global Colorectal Cancer Diagnostics Market, Regulations
- 6.1 Regulatory Scenario In The U.S
- 6.2 Regulatory Scenario In Australia
- 6.3 Regulatory Scenario In Japan
- 6.4 Regulatory Scenario In China
- 7 Market Overview
- 7.1 Drivers
- 7.1.1 Growing Prevalence Of Colorectal Cancer
- 7.1.2 Rise In The Number Of Patients Suffering From Diverticulitis And Ulcerative Colitis.
- 7.1.3 Rising Preference For Preventive Health Check-ups
- 7.2 Restraints
- 7.2.1 Stringent Regulatory Policies
- 7.2.2 High Cost For The Colorectal Cancer Treatments.
- 7.3 Opportunities
- 7.3.1 Rise In Healthcare Expenditure For Cancer Diagnosis And Treatment
- 7.3.2 Government Initiatives Toward Cancer Diagnostics
- 7.3.3 Strategic Initiatives By Market Players
- 7.4 Challenges
- 7.4.1 Increased Cost, Safety, And Convenience Issues
- 7.4.2 Lack Of Skilled And Certified Professionals
- 8 Global Colorectal Cancer Diagnostics Market, By Product Type
- 8.1 Overview
- 8.2 Instruments
- 8.2.1 Pathology-based Instruments
- 8.2.1.1 Pcr Instruments
- 8.2.1.2 Slide Staining Systems
- 8.2.1.3 Tissue Processing Systems
- 8.2.1.4 Cell Processors
- 8.2.1.5 Other Pathology-based Instruments
- 8.2.2 Imaging Instruments
- 8.2.2.1 Ultrasound Systems
- 8.2.2.2 Ct Systems
- 8.2.2.3 Mri Systems
- 8.2.2.4 Others
- 8.2.3 Biopsy Instruments
- 8.2.4 Others
- 8.3 Consumables & Accessories
- 8.3.1 Kits
- 8.3.1.1 Pcr Kits
- 8.3.1.2 Dna Polymerase Kits
- 8.3.1.3 Nucleic Acid Isolation Kits
- 8.3.1.4 Others
- 8.3.2 Reagents
- 8.3.2.1 Assays
- 8.3.2.2 Buffers
- 8.3.2.3 Primers
- 8.3.2.4 Others
- 8.3.3 Other Consumables
- 9 Global Colorectal Cancer Diagnostics Market, By Test Type
- 9.1 Overview
- 9.2 Stool Examination
- 9.3 Blood Test
- 9.3.1 Complete Blood Count (Cbc)
- 9.3.2 Tumor Marker Test
- 9.3.3 Liver Enzyme Blood Test
- 9.4 Imaging Test
- 9.4.1 Computed Tomography (Ct) Scan
- 9.4.2 Mri
- 9.4.3 Ultrasound
- 9.4.4 Position Emission Tomography (Pet)
- 9.4.5 Others
- 9.5 Tumor Markers
- 9.5.1 Carcinoembryonic Antigen (Cea)
- 9.5.2 Ca19-9 Biomarker Test
- 9.5.3 Ca 50 Marker Test
- 9.5.4 Others
- 9.6 Biopsy
- 9.7 Others
- 10 Global Colorectal Cancer Diagnostics Market, By Cancer Stages
- 10.1 Overview
- 10.2 Stage Iii
- 10.3 Stage Iv
- 10.4 Stage Ii
- 10.5 Stage I
- 10.6 Stage 0
- 11 Global Colorectal Cancer Diagnostics Market, By Age Group
- 11.1 Overview
- 11.2 Geriatric
- 11.3 Adults
- 11.4 Pediatric
- 12 Global Colorectal Cancer Diagnostics Market, By Cancer Type
- 12.1 Overview
- 12.2 Adenocarcinoma
- 12.3 Colorectal Lymphoma
- 12.4 Gastrointestinal Stromal Tumors
- 12.5 Carcinoid Tumors
- 12.6 Others
- 13 Global Colorectal Cancer Diagnostics Market, By End User
- 13.1 Overview
- 13.2 Hospitals
- 13.3 Diagnostic Centers
- 13.4 Cancer Research Centers
- 13.5 Ambulatory Surgical Centers
- 13.6 Academic Institutes
- 13.7 Others
- 14 Global Colorectal Cancer Diagnostics Market, By Region
- 14.1 Overview
- 14.2 North America
- 14.2.1 U.S.
- 14.2.2 Canada
- 14.2.3 Mexico
- 14.3 Europe
- 14.3.1 Germany
- 14.3.2 France
- 14.3.3 U.K.
- 14.3.4 Italy
- 14.3.5 Spain
- 14.3.6 Russia
- 14.3.7 Turkey
- 14.3.8 Netherlands
- 14.3.9 Belgium
- 14.3.10 Switzerland
- 14.3.11 Rest Of Europe
- 14.4 Asia-pacific
- 14.4.1 China
- 14.4.2 India
- 14.4.3 Japan
- 14.4.4 South Korea
- 14.4.5 Thailand
- 14.4.6 Singapore
- 14.4.7 Indonesia
- 14.4.8 Malaysia
- 14.4.9 Philippines
- 14.4.10 Australia
- 14.4.11 Vietnam
- 14.4.12 Rest Of Asia-pacific
- 14.5 South America
- 14.5.1 Brazil
- 14.5.2 Argentina
- 14.5.3 Rest Of South America
- 14.6 Middle East And Africa
- 14.6.1 South Africa
- 14.6.2 Saudi Arabia
- 14.6.3 U.A.E.
- 14.6.4 Egypt
- 14.6.5 Israel
- 14.6.6 Rest Of Middle East And Africa
- 15 Global Colorectal Cancer Diagnostics Market, Company Landscape
- 15.1 Company Share Analysis: Global
- 15.2 Company Share Analysis: North America
- 15.3 Company Share Analysis: Europe
- 15.4 Company Share Analysis: Asia-pacific
- 16 Swot Analysis
- 17 Company Profile
- 17.1 F. Hoffmann- La Roche Ltd
- 17.1.1 Company Snapshot
- 17.1.2 Revenue Analysis
- 17.1.3 Company Share Analysis
- 17.1.4 Product Portfolio
- 17.1.5 Recent Development
- 17.2 Koninklijke Philips N.V.
- 17.2.1 Company Snapshot
- 17.2.2 Revenue Analysis
- 17.2.3 Company Share Analysis
- 17.2.4 Product Portfolio
- 17.2.5 Recent Development
- 17.3 Thermo Fisher Scientific Inc.
- 17.3.1 Company Snapshot
- 17.3.2 Revenue Analysis
- 17.3.3 Company Share Analysis
- 17.3.4 Product Portfolio
- 17.3.5 Recent Development
- 17.4 Illumina, Inc.
- 17.4.1 Company Snapshot
- 17.4.2 Revenue Analysis
- 17.4.3 Company Share Analysis
- 17.4.4 Product Portfolio
- 17.4.5 Recent Development
- 17.5 Quest Diagnostics Incorporated
- 17.5.1 Company Snapshot
- 17.5.2 Revenue Analysis
- 17.5.3 Company Share Analysis
- 17.5.4 Product Portfolio
- 17.5.5 Recent Development
- 17.6 Abbott
- 17.6.1 Company Snapshot
- 17.6.2 Revenue Analysis
- 17.6.3 Product Portfolio
- 17.6.4 Recent Development
- 17.7 Agilent Technologies, Inc.
- 17.7.1 Company Snapshot
- 17.7.2 Revenue Analysis
- 17.7.3 Product Portfolio
- 17.7.4 Recent Development
- 17.8 Bd
- 17.8.1 Company Snapshot
- 17.8.2 Revenue Analysis
- 17.8.3 Product Portfolio
- 17.8.4 Recent Development
- 17.9 Beijing O&D Biotech Co., Ltd.
- 17.9.1 Company Snapshot
- 17.9.2 Product Portfolio
- 17.9.3 Recent Development
- 17.10 Biofire Diagnostics
- 17.10.1 Company Snapshot
- 17.10.2 Revenue Analysis
- 17.10.3 Product Portfolio
- 17.10.4 Recent Development
- 17.11 Bio-rad Laboratories, Inc.
- 17.11.1 Company Snapshot
- 17.11.2 Revenue Analysis
- 17.11.3 Product Portfolio
- 17.11.4 Recent Development
- 17.12 Canon Medical Systems Corporation.
- 17.12.1 Company Snapshot
- 17.12.2 Revenue Analysis
- 17.12.3 Product Portfolio
- 17.12.4 Recent Development
- 17.13 Fonar Corp.
- 17.13.1 Company Snapshot
- 17.13.2 Revenue Analysis
- 17.13.3 Product Portfolio
- 17.13.4 Recent Development
- 17.14 Fujifilm Corporation
- 17.14.1 Company Snapshot
- 17.14.2 Revenue Analysis
- 17.14.3 Product Portfolio
- 17.14.4 Recent Development
- 17.15 Ge Healthcare.
- 17.15.1 Company Snapshot
- 17.15.2 Revenue Analysis
- 17.15.3 Product Portfolio
- 17.15.4 Recent Development
- 17.16 Hologic, Inc.
- 17.16.1 Company Snapshot
- 17.16.2 Revenue Analysis
- 17.16.3 Product Portfolio
- 17.16.4 Recent Development 383
- List Of Tables
- Table 1 Global Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 2 Global Instruments In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 3 Global Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 4 Global Pathology-based Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 5 Global Imaging Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 6 Global Consumables & Accessories In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 7 Global Consumables And Accessories In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 8 Global Kits In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 9 Global Reagents In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 10 Global Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 11 Global Stool Examination In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 12 Global Blood Test In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 13 Global Blood Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 14 Global Imaging Test In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 15 Global Imaging Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 16 Global Tumor Markers In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 17 Global Tumor Markers In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 18 Global Biopsy In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 19 Global Others In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 20 Global Colorectal Cancer Diagnostics Market, By Cancer Stages, 2021-2030 (Usd Million)
- Table 21 Global Stage Iii In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 22 Global Stage Iv In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 23 Global Stage Ii In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 24 Global Stage I In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 25 Global Stage 0 In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 26 Global Colorectal Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 27 Global Geriatric In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 28 Global Adults In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 29 Global Pediatric In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 30 Global Colorectal Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 31 Global Adenocarcinoma In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 32 Global Colorectal Lymphoma In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 33 Global Gastrointestinal Stromal Tumors In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 34 Global Carcinoid Tumors In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 35 Global Others In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 36 Global Colorectal Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 37 Global Hospitals In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 38 Global Diagnostic Centers In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 39 Global Cancer Research Centers In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 40 Global Ambulatory Surgical Centers In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 41 Global Academic Institutes In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 42 Global Others In Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 43 Global Colorectal Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 44 North America Colorectal Cancer Diagnostics Market, By Country, 2021-2030 (Usd Million)
- Table 45 North America Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 46 North America Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 47 North America Pathology-based Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 48 North America Imaging Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 49 North America Consumables & Accessories In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 50 North America Kits In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 51 North America Reagents In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 52 North America Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 53 North America Blood Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 54 North America Imaging Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 55 North America Tumor Markers In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 56 North America Colorectal Cancer Diagnostics Market, By Cancer Stages, 2021-2030 (Usd Million)
- Table 57 North America Colorectal Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 58 North America Colorectal Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 59 North America Colorectal Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 60 U.S. Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 61 U.S. Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 62 U.S. Pathology-based Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 63 U.S. Imaging Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 64 U.S. Consumables & Accessories In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 65 U.S. Kits In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 66 U.S. Reagents In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 67 U.S. Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 68 U.S. Blood Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 69 U.S. Imaging Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 70 U.S. Tumor Markers In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 71 U.S. Colorectal Cancer Diagnostics Market, By Cancer Stages, 2021-2030 (Usd Million)
- Table 72 U.S. Colorectal Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 73 U.S. Colorectal Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 74 U.S. Colorectal Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 75 Canada Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 76 Canada Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 77 Canada Pathology-based Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 78 Canada Imaging Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 79 Canada Consumables & Accessories In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 80 Canada Kits In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 81 Canada Reagents In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 82 Canada Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 83 Canada Blood Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 84 Canada Imaging Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 85 Canada Tumor Markers In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 86 Canada Colorectal Cancer Diagnostics Market, By Cancer Stages, 2021-2030 (Usd Million)
- Table 87 Canada Colorectal Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 88 Canada Colorectal Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 89 Canada Colorectal Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 90 Mexico Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 91 Mexico Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 92 Mexico Pathology-based Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 93 Mexico Imaging Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 94 Mexico Consumables & Accessories In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 95 Mexico Kits In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 96 Mexico Reagents In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 97 Mexico Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 98 Mexico Blood Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 99 Mexico Imaging Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 100 Mexico Tumor Markers In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 101 Mexico Colorectal Cancer Diagnostics Market, By Cancer Stages, 2021-2030 (Usd Million)
- Table 102 Mexico Colorectal Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 103 Mexico Colorectal Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 104 Mexico Colorectal Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 105 Europe Colorectal Cancer Diagnostics Market, By Country, 2021-2030 (Usd Million)
- Table 106 Europe Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 107 Europe Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 108 Europe Pathology-based Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 109 Europe Imaging Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 110 Europe Consumables & Accessories In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 111 Europe Kits In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 112 Europe Reagents In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 113 Europe Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 114 Europe Blood Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 115 Europe Imaging Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 116 Europe Tumor Markers In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 117 Europe Colorectal Cancer Diagnostics Market, By Cancer Stages, 2021-2030 (Usd Million)
- Table 118 Europe Colorectal Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 119 Europe Colorectal Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 120 Europe Colorectal Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 121 Germany Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 122 Germany Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 123 Germany Pathology-based Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 124 Germany Imaging Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 125 Germany Consumables & Accessories In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 126 Germany Kits In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 127 Germany Reagents In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 128 Germany Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 129 Germany Blood Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 130 Germany Imaging Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 131 Germany Tumor Markers In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 132 Germany Colorectal Cancer Diagnostics Market, By Cancer Stages, 2021-2030 (Usd Million)
- Table 133 Germany Colorectal Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 134 Germany Colorectal Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 135 Germany Colorectal Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 136 France Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 137 France Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 138 France Pathology-based Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 139 France Imaging Instruments In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 140 France Consumables & Accessories In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 141 France Kits In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 142 France Reagents In Colorectal Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 143 France Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 144 France Blood Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 145 France Imaging Test In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 146 France Tumor Markers In Colorectal Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
- Table 147 France Colorectal Cancer Diagnostics Market, By Cancer Stages, 2021-2030 (Usd Million)
- Table 148 France Colorectal Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
- Table 149 France Colorectal Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- List Of Figures
- Figure 1 Global Colorectal Cancer Diagnostics Market: Segmentation
- Figure 2 Global Colorectal Cancer Diagnostics Market: Data Triangulation
- Figure 3 Global Colorectal Cancer Diagnostics Market: Droc Analysis
- Figure 4 Global Colorectal Cancer Diagnostics Market: Global Vs Regional Market Analysis
- Figure 5 Global Colorectal Cancer Diagnostics Market: Company Research Analysis
- Figure 6 Global Colorectal Cancer Diagnostics Market: Interview Demographics
- Figure 7 Global Colorectal Cancer Diagnostics Market: Dbmr Market Position Grid
- Figure 8 Global Colorectal Cancer Diagnostics Market: Market End User Coverage Grid
- Figure 9 Global Colorectal Cancer Diagnostics Market: Vendor Share Analysis
- Figure 10 Global Colorectal Cancer Diagnostics Market: Segmentation
- Figure 11 The Increase In The Awareness About Colorectal Cancer Is Expected To Drive The Global Colorectal Cancer Diagnostics Market Growth In The Forecast Period
- Figure 12 The Instruments Segment Is Expected To Account For The Largest Share Of The Global Colorectal Cancer Diagnostics Market In 2023 & 2030
- Figure 13 North America Is Expected To Dominate The Global Colorectal Cancer Diagnostics Market, And Asia-pacific Is Expected To Grow With The Highest Cagr In The Forecast Period
- Figure 14 Asia-pacific Is The Fastest-growing Market For Global Colorectal Cancer Diagnostics Market Manufacturers In The Forecast Period
- Figure 15 Drivers, Restraints, Opportunities, And Challenges Of The Global Colorectal Cancer Diagnostics Market
- Figure 16 Global Colorectal Cancer Diagnostics Market: By Product Type, 2022
- Figure 17 Global Colorectal Cancer Diagnostics Market: By Product Type, 2023-2030 (Usd Million)
- Figure 18 Global Colorectal Cancer Diagnostics Market: By Product Type, Cagr (2023-2030)
- Figure 19 Global Colorectal Cancer Diagnostics Market: By Product Type, Lifeline Curve
- Figure 20 Global Colorectal Cancer Diagnostics Market: By Test Type, 2022
- Figure 21 Global Colorectal Cancer Diagnostics Market: By Test Type, 2023-2030 (Usd Million)
- Figure 22 Global Colorectal Cancer Diagnostics Market: By Test Type, Cagr (2023-2030)
- Figure 23 Global Colorectal Cancer Diagnostics Market: By Test Type, Lifeline Curve
- Figure 24 Global Colorectal Cancer Diagnostics Market: By Cancer Stages, 2022
- Figure 25 Global Colorectal Cancer Diagnostics Market: By Cancer Stages, 2023-2030 (Usd Million)
- Figure 26 Global Colorectal Cancer Diagnostics Market: By Cancer Stages, Cagr (2023-2030)
- Figure 27 Global Colorectal Cancer Diagnostics Market: By Cancer Stages, Lifeline Curve
- Figure 28 Global Colorectal Cancer Diagnostics Market: By Age Group, 2022
- Figure 29 Global Colorectal Cancer Diagnostics Market: By Age Group, 2023-2030 (Usd Million)
- Figure 30 Global Colorectal Cancer Diagnostics Market: By Age Group, Cagr (2023-2030)
- Figure 31 Global Colorectal Cancer Diagnostics Market: By Age Group, Lifeline Curve
- Figure 32 Global Colorectal Cancer Diagnostics Market: By Cancer Type, 2022
- Figure 33 Global Colorectal Cancer Diagnostics Market: By Cancer Type, 2023-2030 (Usd Million)
- Figure 34 Global Colorectal Cancer Diagnostics Market: By Cancer Type, Cagr (2023-2030)
- Figure 35 Global Colorectal Cancer Diagnostics Market: By Cancer Type, Lifeline Curve
- Figure 36 Global Colorectal Cancer Diagnostics Market: By End User, 2022
- Figure 37 Global Colorectal Cancer Diagnostics Market: By End User, 2023-2030 (Usd Million)
- Figure 38 Global Colorectal Cancer Diagnostics Market: By End User, Cagr (2023-2030)
- Figure 39 Global Colorectal Cancer Diagnostics Market: By End User, Lifeline Curve
- Figure 40 Global Colorectal Cancer Diagnostics Market: Snapshot (2022)
- Figure 41 Global Colorectal Cancer Diagnostics Market: By Region (2022)
- Figure 42 Global Colorectal Cancer Diagnostics Market: By Region (2023 & 2030)
- Figure 43 Global Colorectal Cancer Diagnostics Market: By Region (2022 & 2030)
- Figure 44 Global Colorectal Cancer Diagnostics Market: By Product Type (2023-2030)
- Figure 45 North America Colorectal Cancer Diagnostics Market: Snapshot (2022)
- Figure 46 North America Colorectal Cancer Diagnostics Market: By Country (2022)
- Figure 47 North America Colorectal Cancer Diagnostics Market: By Country (2023 & 2030)
- Figure 48 North America Colorectal Cancer Diagnostics Market: By Country (2022 & 2030)
- Figure 49 North America Colorectal Cancer Diagnostics Market: Product Type (2023-2030)
- Figure 50 Europe Colorectal Cancer Diagnostics Market: Snapshot (2022)
- Figure 51 Europe Colorectal Cancer Diagnostics Market: By Country (2022)
- Figure 52 Europe Colorectal Cancer Diagnostics Market: By Country (2023 & 2030)
- Figure 53 Europe Colorectal Cancer Diagnostics Market: By Country (2022 & 2030)
- Figure 54 Europe Colorectal Cancer Diagnostics Market: Product Type (2023-2030)
- Figure 55 Asia-pacific Colorectal Cancer Diagnostics Market: Snapshot (2022)
- Figure 56 Asia-pacific Colorectal Cancer Diagnostics Market: By Country (2022)
- Figure 57 Asia-pacific Colorectal Cancer Diagnostics Market: By Country (2023 & 2030)
- Figure 58 Asia-pacific Colorectal Cancer Diagnostics Market: By Country (2022 & 2030)
- Figure 59 Asia-pacific Colorectal Cancer Diagnostics Market: Product Type (2023-2030)
- Figure 60 South America Colorectal Cancer Diagnostics Market: Snapshot (2022)
- Figure 61 South America Colorectal Cancer Diagnostics Market: By Country (2022)
- Figure 62 South America Colorectal Cancer Diagnostics Market: By Country (2023 & 2030)
- Figure 63 South America Colorectal Cancer Diagnostics Market: By Country (2022 & 2030)
- Figure 64 South America Colorectal Cancer Diagnostics Market: Product Type (2023-2030)
- Figure 65 Middle East And Africa Colorectal Cancer Diagnostics Market: Snapshot (2022)
- Figure 66 Middle East And Africa Colorectal Cancer Diagnostics Market: By Country (2022)
- Figure 67 Middle East And Africa Colorectal Cancer Diagnostics Market: By Country (2023 & 2030)
- Figure 68 Middle East And Africa Colorectal Cancer Diagnostics Market: By Country (2022 & 2030)
- Figure 69 Middle East And Africa Colorectal Cancer Diagnostics Market: Product Type (2023-2030)
- Figure 70 Global Colorectal Cancer Diagnostics Market: Company Share 2022 (%)
- Figure 71 North America Colorectal Cancer Diagnostics Market: Company Share 2022 (%)
- Figure 72 Europe Colorectal Cancer Diagnostics Market: Company Share 2022 (%)
- Figure 73 Asia-pacific Colorectal Cancer Diagnostics Market: Company Share 2022 (%) 350
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.